VIA
AGN

Vident Investment Advisory’s Allergan plc AGN Stock Holding History

Vident Investment Advisory’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,659
Closed -$508K – 865
2019
Q4 		$508K Buy
2,659
+164
+7% +$29.6K 0.03% 553
2019
Q3 		$420K Sell
2,495
-1,954
-44% -$318K 0.04% 387
2019
Q2 		$745K Sell
4,449
-18,796
-81% -$2.6M 0.06% 219
2019
Q1 		$3.4M Buy
23,245
+2,945
+15% +$427K 0.18% 104
2018
Q4 		$2.71M Sell
20,300
-332
-2% -$54.4K 0.15% 142
2018
Q3 		$3.93M Buy
20,632
+19,156
+1,298% +$3.52M 0.15% 130
2018
Q2 		$246K Sell
1,476
-2,495
-63% -$401K 0.01% 835
2018
Q1 		$661K Sell
3,971
-1,334
-25% -$224K 0.03% 498
2017
Q4 		$868K Sell
5,305
-747
-12% -$134K 0.04% 395
2017
Q3 		$1.24M Buy
6,052
+4,745
+363% +$1.1M 0.07% 339
2017
Q2 		$318K Buy
1,307
+23
+2% +$5.41K 0.03% 374
2017
Q1 		$307K Buy
+1,284
New +$299K 0.03% 378
2016
Q4 		– Sell
-2,062
Closed -$475K – 399
2016
Q3 		$475K Buy
+2,062
New +$504K 0.06% 365
2016
Q2 		– Sell
-41,640
Closed -$11.2K – 398
2016
Q1 		$11.2K Buy
41,640
+25,409
+157% +$7.27M 0.69% 4
2015
Q4 		$5.07M Sell
16,231
-9,201
-36% -$2.74M 0.64% 3
2015
Q3 		$6.91M Buy
25,432
+13,185
+108% +$4.05M 0.96% 4
2015
Q2 		$3.72M Buy
+12,247
New +$3.65M 0.49% 31

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vident Investment Advisory's AGN Position: Q1 2020 in Review

Vident Investment Advisory sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 2,659 shares — an estimated $508K sold.

Vident Investment Advisory first reported a position in AGN in Q2 2015 and held it in 17 quarters. The position peaked at $6.91M in Q3 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Vident Investment Advisory reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Vident Investment Advisory sold 2,659 Allergan plc shares in Q1 2020, an estimated $508K.
  • Vident Investment Advisory first reported a position in Allergan plc in Q2 2015 and held it in 17 quarters.
  • Vident Investment Advisory's Allergan plc position peaked at $6.91M in Q3 2015.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Vident Investment Advisory's 13F filing for Q1 2020, filed 12 May 2020.